C07C 237/14
The carbon skeleton being saturated and containing rings
Official title: the carbon skeleton being saturated and containing rings
C07C237/14 (The carbon skeleton being saturated and containing rings) appears on 31 US grants and 34 published applications in this corpus.
Search patents in C07C- Granted patents
- 31
- Published applications
- 34
- Assignees
- 38
- Inventors
- 152
- Latest grant
- 4 Jun 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 2 | 0 |
| 1998 | 2 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 0 |
| 2003 | 1 | 1 |
| 2004 | 0 | 4 |
| 2005 | 1 | 1 |
| 2006 | 4 | 3 |
| 2007 | 1 | 0 |
| 2008 | 0 | 0 |
| 2009 | 1 | 4 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 3 | 4 |
| 2013 | 1 | 3 |
| 2014 | 3 | 2 |
| 2015 | 0 | 0 |
| 2016 | 1 | 1 |
| 2017 | 0 | 1 |
| 2018 | 0 | 1 |
| 2019 | 0 | 1 |
| 2020 | 1 | 0 |
| 2021 | 1 | 3 |
| 2022 | 2 | 0 |
| 2023 | 0 | 2 |
| 2024 | 1 | 1 |
| 2025 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- YAP1 inhibitors that target the interaction of YAP1 with OCT44 Jun 2024US 11,999,695 B2H. Lee Moffitt Cancer Center and Research Institute, Inc.
- YAP1 inhibitors that target the interaction of YAP1 with Oct420 Dec 2022US 11,530,182 B2H. Lee Moffitt Cancer Center and Research Institute, Inc.
- Substituted [1.1.1] bicyclo compounds as indoleamine 2,3-dioxygenase inhibitors7 Jun 2022US 11,352,320 B2Merck Sharp & Dohme Corp.
- YAP1 inhibitors that target the interaction of YAP1 with OCT42 Feb 2021US 10,906,874 B2H. Lee Moffitt Cancer Center and Research Institute, Inc.
- Antibacterial compounds and methods of making and using same10 Nov 2020US 10,829,440 B2Brown University
- Compositions of matter from unsaturated nitriles1 May 2025US 2025/0136561 A1INV Nylon Chemicals Americas, LLC
- Novel adamantyl derivative or pharmaceutically acceptable salt thereof, and use thereof16 May 2024US 2024/0158352 A1CAN-Therapy Inc.
- Lipid compounds and lipid nanoparticle compositions2 Nov 2023US 2023/0348362 A1Suzhou Abogen Biosciences Co., Ltd.
- Yap1 inhibitors that target the interaction of yap1 with oct427 Jul 2023US 2023/0234924 A1H. Lee Moffitt Cancer Center and Research Institute, Inc.
- Novel substituted [1.1.1] bicyclo compounds as indoleamine 2,3-dioxygenase inhibitors1 Jul 2021US 2021/0198190 A1Merck Sharp & Dohme Corp.
Most cited
By later US patents
- 5-amino-6-cyclohexyl-4-hydroxy-hexanamide derivatives as inhibitors of .beta.-amyloid protein production83US 5,703,129 ABristol-Myers Squibb Company · 1997
- Substituted diarylalkyl amides as calcium channel antagonists39US 6,458,781 B12002
- Substituted β-amino acid inhibitors of methionine aminopeptidase-229US 6,242,494 B1Abbott Laboratories · 2001
- Process for the production of DTPA-monoamides of the central carboxylic acid and their use as pharmaceutical agents14US 5,679,852 ASchering Corporation · 1997
- Substituted peptidylamine calcium channel blockers12US 6,117,841 AWarner-Lambert Company · 2000